Get started
RocketTickers

Regulus Therapeutics Announces FDA Orphan Drug Designation of RG

Long
Regulus Therapeutics Inc. (NASDAQ:RGLS)  
RocketTickers  
NASDAQ:RGLS   Regulus Therapeutics Inc.
Beyond Technical Analysis
1
0
beyondta
RGLS: Regulus Therapeutics Inc.
2020-07-29 08:07:00
Regulus Therapeutics Announces FDA Orphan Drug Designation of RGLS4326 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.